CBIO

Crescent Biopharma, Inc. Common Stock

85 hedge funds and large institutions have $668M invested in Crescent Biopharma, Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 31 increasing their positions, 25 reducing their positions, and 10 closing their positions.

Holders
85
Holders Change
+1
Holders Change %
+1.19%
% of All Funds
1.95%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
11
Increased
31
Reduced
25
Closed
10
Calls
$1.53M
Puts
$1.23M
Net Calls
+$304K
Net Calls Change
-$215K
Name Market Value Shares Shares
Change
Shares
Change %
FQ
76
First Quadrant
California
$18K 1,279 +1,279 New
BNP Paribas Financial Markets
77
BNP Paribas Financial Markets
France
$15.8K 1,099
PA
78
Perennial Advisors
New York
$14K 1,000
Royal Bank of Canada
79
Royal Bank of Canada
Ontario, Canada
$13K 873 +873 New
PCM
80
Prelude Capital Management
New York
$8K 541 +221 +69%
SFG
81
SevenBridge Financial Group
Pennsylvania
$7K 500
Macquarie Group
82
Macquarie Group
Australia
$6K 400 -4,400 -92%
Bank of Montreal
83
Bank of Montreal
Ontario, Canada
$3K 235 -5,004 -96%
TWA
84
TCI Wealth Advisors
Arizona
$3K 200 -200 -50%
Daiwa Securities Group
85
Daiwa Securities Group
Japan
$3K 190
PC
86
Polar Capital
United Kingdom
-1,047,615 Closed
BBA
87
Baker Bros. Advisors
New York
-291,214 Closed
AG
88
Artal Group
Luxembourg
-250,000 Closed
SSA
89
Schonfeld Strategic Advisors
New York
-140,000 Closed
Millennium Management
90
Millennium Management
New York
-131,231 Closed
GH
91
GAM Holding
Switzerland
-77,900 Closed
ARTA
92
A.R.T. Advisors
New York
-27,147 Closed
Group One Trading
93
Group One Trading
Illinois
-1,703 Closed
Simplex Trading
94
Simplex Trading
Illinois
-825 Closed
PIA
95
Piedmont Investment Advisors
North Carolina
-584 Closed
CFGS
96
Concourse Financial Group Securities
Alabama
Susquehanna International Group
97
Susquehanna International Group
Pennsylvania